118 related articles for article (PubMed ID: 11360429)
1. Optimization of an exogenous metabolic activation system for FETAX. I. Post-isolation rat liver microsome mixtures.
Fort DJ; Rogers RL; Stover EL; Finch RA
Drug Chem Toxicol; 2001 May; 24(2):103-15. PubMed ID: 11360429
[TBL] [Abstract][Full Text] [Related]
2. Assessing the efficacy of an Aroclor 1254-induced exogenous metabolic activation system for FETAX.
Fort DJ; Rayburn JR; DeYoung DJ; Bantle JA
Drug Chem Toxicol; 1991; 14(1-2):143-60. PubMed ID: 1889373
[TBL] [Abstract][Full Text] [Related]
3. Optimization of an exogenous metabolic activation system for FETAX. II. Preliminary evaluation.
Fort DJ; Rogers RL; Paul RR; Stover EL; Finch RA
Drug Chem Toxicol; 2001 May; 24(2):117-27. PubMed ID: 11360430
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the mechanism of isoniazid-induced developmental toxicity with frog embryo teratogenesis assay: Xenopus (FETAX).
Fort DJ; Bantle JA
Teratog Carcinog Mutagen; 1990; 10(6):463-76. PubMed ID: 1982910
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the developmental toxicity of five compounds with the frog embryo teratogenesis assay: Xenopus (FETAX) and a metabolic activation system.
Fort DJ; James BL; Bantle JA
J Appl Toxicol; 1989 Dec; 9(6):377-88. PubMed ID: 2613998
[TBL] [Abstract][Full Text] [Related]
6. Phase III interlaboratory study of FETAX, Part 2: interlaboratory validation of an exogenous metabolic activation system for frog embryo teratogenesis assay--Xenopus (FETAX).
Fort DJ; Stover EL; Bantle JA; Rayburn JR; Hull MA; Finch RA; Burton DT; Turley SD; Dawson DA; Linder G; Buchwalter D; Dumont JN; Kumsher-King M; Gaudet-Hull AM
Drug Chem Toxicol; 1998 Feb; 21(1):1-14. PubMed ID: 9530526
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the developmental toxicities of coumarin, 4-hydroxycoumarin, and 7-hydroxycoumarin using FETAX.
Fort DJ; Stover EL; Propst T; Hull MA; Bantle JA
Drug Chem Toxicol; 1998 Feb; 21(1):15-26. PubMed ID: 9530527
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the developmental toxicity of thalidomide using frog embryo teratogenesis assay-xenopus (FETAX): biotransformation and detoxification.
Fort DJ; Stover EL; Bantle JA; Finch RA
Teratog Carcinog Mutagen; 2000; 20(1):35-47. PubMed ID: 10607376
[TBL] [Abstract][Full Text] [Related]
9. Development of a metabolic activation system for the frog embryo teratogenesis assay: Xenopus (FETAX).
Fort DJ; Dawson DA; Bantle JA
Teratog Carcinog Mutagen; 1988; 8(5):251-63. PubMed ID: 2905834
[TBL] [Abstract][Full Text] [Related]
10. Phase III interlaboratory study of FETAX. Part 3. FETAX validation using 12 compounds with and without an exogenous metabolic activation system.
Bantle JA; Finch RA; Fort DJ; Stover EL; Hull M; Kumsher-King M; Gaudet-Hull AM
J Appl Toxicol; 1999; 19(6):447-72. PubMed ID: 10547627
[TBL] [Abstract][Full Text] [Related]
11. Use of Frog Embryo Teratogenesis Assay-Xenopus and an exogenous metabolic activation system to evaluate the developmental toxicity of diphenylhydantoin.
Fort DJ; Bantle JA
Fundam Appl Toxicol; 1990 May; 14(4):720-33. PubMed ID: 2361573
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the developmental toxicity of benzo[a]pyrene and 2-acetylaminofluorene using Xenopus: modes of biotransformation. Stover Group.
Propst TL; Fort DJ; Stover EL; Schrock B; Bantle JA
Drug Chem Toxicol; 1997; 20(1-2):45-61. PubMed ID: 9183562
[TBL] [Abstract][Full Text] [Related]
13. Human liver S-9 metabolic activation: proficiency in cytogenetic assays and comparison with phenobarbital/beta-naphthoflavone or aroclor 1254 induced rat S-9.
Johnson TE; Umbenhauer DR; Galloway SM
Environ Mol Mutagen; 1996; 28(1):51-9. PubMed ID: 8698047
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the developmental toxicity of nicotine and cotinine with frog embryo teratogenesis assay: Xenopus.
Dawson DA; Fort DJ; Smith GJ; Newell DL; Bantle JA
Teratog Carcinog Mutagen; 1988; 8(6):329-38. PubMed ID: 2905544
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the developmental toxicities of ethanol, acetaldehyde, and thioacetamide using FETAX.
Fort DJ; McLaughlin DW; Rogers RL; Buzzard BO
Drug Chem Toxicol; 2003 Feb; 26(1):23-34. PubMed ID: 12643038
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the developmental toxicity of caffeine and caffeine metabolites using the frog embryo teratogenesis assay--Xenopus (FETAX).
Fort DJ; Stover EL; Propst TL; Faulkner BC; Vollmuth TA; Murray FJ
Food Chem Toxicol; 1998 Jul; 36(7):591-600. PubMed ID: 9687966
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the developmental toxicity of ascorbic acid, sodium selenate, coumarin, serotonin, and 13-cis retinoic acid using FETAX.
DeYoung DJ; Bantle JA; Fort DJ
Drug Chem Toxicol; 1991; 14(1-2):127-41. PubMed ID: 1889372
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the developmental toxicity of trichloroethylene and detoxification metabolites using Xenopus.
Fort DJ; Stover EL; Rayburn JR; Hull M; Bantle JA
Teratog Carcinog Mutagen; 1993; 13(1):35-45. PubMed ID: 8100651
[TBL] [Abstract][Full Text] [Related]
19. Further validation of FETAX: evaluation of the developmental toxicity of five known mammalian teratogens and non-teratogens.
Bantle JA; Fort DJ; Rayburn JR; DeYoung DJ; Bush SJ
Drug Chem Toxicol; 1990; 13(4):267-82. PubMed ID: 1703942
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of acetaminophen-induced developmental toxicity using FETAX.
Fort DJ; Rayburn JR; Bantle JA
Drug Chem Toxicol; 1992; 15(4):329-50. PubMed ID: 1459044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
